... -202A>C polymorphism and PCa risk in humans. However, the results remain inconclusive and inconsistent. Hence, we performed a meta-analysis of all eligible case-control studies. Methods: We used odds ratios (ORs) with 95% confidence intervals (CIs) to assess the strength of the association. Results...

... was compared with that of a control group. Methods: Serum and urinary biochemistry related to urolithiasis were evaluated in 105 males diagnosed with recurrent kidney calcium stones and 101 age-matched healthy control males. The polymerase chain reaction single-strand conformation polymorphism method was used...

... to clarify the influence of a common insertion/deletion polymorphism (-94 ins/del ATTG, rs28362491) in the NFKB1 promoter on RCC susceptibility. Methods: We genotyped the NFKB1 -94 ins/del ATTG promoter polymorphism by the TaqMan method and assessed the association with RCC risk, clinicopathological...

...Hongtuan Zhang; Zhihong Zhang; Jingsheng Wu; Yong Xu; Ru Cheng; Li Li Background: The relationship of prostate cancer (PCa) with the presence of catechol-O-methyltransferase (COMT) genetic polymorphism Val158Met (158G/A) has been reported with inconsistent results. The objective of this study...

...Shimiao Zhu; Hui Zhang; Yang Tang; Jianmin Wang Objective: To examine the association between XPD and hOGG1 polymorphisms and prostate cancer (PCa) susceptibility. Methods: A comprehensive search was conducted to identify all case-control studies on the relationship between XPD and hOGG1...

...Dawei Li; Hainan Liu; Lei Yan; Yueqing Tang; Juchao Ren; Zhonghua Xu Objective: In some but not all studies, hOGG1 Ser326Cys polymorphism has been reported to contribute to the risk of bladder cancer. To determine whether there is a significant association of hOGG1 Ser326Cys polymorphism...

...Liu Liwei; Liu Chunyu; Li Jie; Han Ruifa Objectives: To examine the association between fibroblast growth factor receptor-4 (FGFR-4) genetic polymorphisms (Gly-388Arg) and prostate cancer susceptibility. Methods: A comprehensive search was conducted to identify all case-control studies of FGFR-4...

... the potential relationship, a meta-analysis was conducted. Methods: Eligible studies were retrieved via both computerized searches and review of references. The relation of VDR polymorphisms to urolithiasis was quantified on Apa I, Bsm I, Fok I and Taq I separately. Stratified analyses on regional...

... to in the content or advertisements. Bladder cancer Polymorphism Biological tumor markers GSTT1 Urologia Internationalis Original Paper Urol Int 2011;86:41 46 DOI: 10.1159/000321689 Received: April 26, 2010 Accepted: September 26, 2010 Published online: November 16, 2010 GSTT1: A Marker...

... in the development of many human tumors. We investigated the potential prognostic roles of p53 codon 72 and MDM2 309 and 1797 polymorphisms in prostate cancer after radical prostatectomy. Patients and Methods: Fifty southern Chinese with prostate cancer undergoing radical prostatectomy were included in this study...

... to be a neurobiological dysfunction with genetic vulnerability and is related to disturbances of central serotonin (5-hydroxytryptamine, 5-HT) neurotransmission and 5-HT receptor function. Aim: To investigate the relationship between the C–759T and G–697C polymorphisms of the 5-HT 2C receptor and LPE. Methods...

... is associated with tumor grade and advanced clinical stage. A –160 C→A polymorphism in the promoter region of E-cadherin has been shown to decrease gene transcription. This allelic variation may be a potential genetic marker that can help identify those individuals at higher risk for invasive/metastatic disease...